However, once the benzimidazole is detached from cobalt by quaternization with methyl iodide, it is replaced by H 2 O or hydroxyl ions
The SELECT trial, published in the New England Journal of Medicine in 2023, demonstrated that semaglutide significantly reduced major adverse cardiovascular events in patients with established cardiovascular disease and overweight or obesity, representing a landmark finding for GLP-1 receptor agonists in cardiovascular risk reduction
Other recognised adverse effects include: Injection site reactions (redness, itching) Fatigue (uncommon) Dizziness (uncommon) A modest increase in heart rate has been observed Gallbladder disorders , including cholecystitis and cholelithiasis Diabetic retinopathy complications (particularly in patients with pre-existing retinopathy and rapid improvement in glycaemic control) Acute pancreatitis (uncommon) Dysgeusia (taste disturbance) Increases in pancreatic enzymes (amylase/lipase) Serious allergic reactions, though rare, require immediate medical attention
However, it is important to note that many of these serotonin-targeted weight-loss therapies require an intact melanocortin system in order to be effective [108]
At Elite Peptide Core, BPC-157 is presented as part of our Recovery Peptides collection, where users can explore complementary options such as TB-500, GHK-Cu and Thymosin Beta-4
For systemic effects, injection may be preferred
